Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccine
Wakako Furuyama, Kyle Shifflett, Amanda N. Pinski, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 21

Showing 21 citing articles:

Intranasal COVID-19 vaccines: From bench to bed
Aqu Alu, Li Chen, Lei Hong, et al.
EBioMedicine (2022) Vol. 76, pp. 103841-103841
Open Access | Times Cited: 210
COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
Kuldeep Dhama, Manish Dhawan, Ruchi Tiwari, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 75
Delivery Routes for COVID-19 Vaccines
Jang Hyun Park, Heung Kyu Lee
Vaccines (2021) Vol. 9, Iss. 5, pp. 524-524
Open Access | Times Cited: 54
Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector
Guodong Liu, Wenguang Cao, Abdjeleel Salawudeen, et al.
Pathogens (2021) Vol. 10, Iss. 9, pp. 1092-1092
Open Access | Times Cited: 54
Olfactory immune response to SARS-CoV-2
Sebastian A. Wellford, E. Ashley Moseman
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 134-143
Open Access | Times Cited: 14
Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization
Alexandru A. Hennrich, Bevan Sawatsky, Rosalía Santos-Mandujano, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 4, pp. e1009064-e1009064
Open Access | Times Cited: 27
Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates
Marieke A. Stammes, Ji Hyun Lee, Lisette Meijer, et al.
Trends in Molecular Medicine (2021) Vol. 28, Iss. 2, pp. 123-142
Open Access | Times Cited: 19
Optimization of Single-Dose VSV-Based COVID-19 Vaccination in Hamsters
Kyle L. O’Donnell, Chad S. Clancy, Amanda J. Griffin, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 13
Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT™ adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice
Chih-Yun Lai, Albert To, Teri Ann S. Wong, et al.
Vaccine X (2021) Vol. 9, pp. 100126-100126
Open Access | Times Cited: 16
Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrina
Jennifer Tisoncik-Go, Kathleen Voss, Thomas B. Lewis, et al.
Frontiers in Virology (2023) Vol. 3
Open Access | Times Cited: 4
An Intramuscular DNA Vaccine for SARS-CoV-2 Decreases Viral Lung Load but Not Lung Pathology in Syrian Hamsters
Shanna Leventhal, Chad S. Clancy, Jesse H. Erasmus, et al.
Microorganisms (2021) Vol. 9, Iss. 5, pp. 1040-1040
Open Access | Times Cited: 11
Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approach
Bhargava Kandala, Nele Plock, Akshita Chawla, et al.
EBioMedicine (2022) Vol. 84, pp. 104264-104264
Open Access | Times Cited: 7
Ebola Virus Glycoprotein Domains Associated with Protective Efficacy
Bharti Bhatia, Wakako Furuyama, Thomas Hoenen, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 630-630
Open Access | Times Cited: 9
Methods for measuring the evolutionary stability of engineered genomes to improve their longevity
Scott L. Nuismer, Nathan C. Layman, Alec Redwood, et al.
Synthetic Biology (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 8
EFCAB4B (CRACR2A) genetic variants associated with COVID-19 fatality
Dapeng Wang, Sabina D. Wiktor, Chew W. Cheng, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19
Aiquan Chang, Jingyou Yu
Viruses (2022) Vol. 14, Iss. 2, pp. 380-380
Open Access | Times Cited: 5
Optimization of single dose VSV-based COVID-19 vaccination in hamsters
Kyle L. O’Donnell, Chad S. Clancy, Amanda J. Griffin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
EFCAB4B (CRACR2A/Rab46) Genetic Variants Associated with COVID-19 Fatality
Dapeng Wang, Sabina D. Wiktor, Chew W. Cheng, et al.
COVID (2024) Vol. 4, Iss. 7, pp. 1087-1099
Open Access
VSV-based vaccine provides species-specific protection against Sudan virus challenge in macaques
Andrea Marzi, Paige Fletcher, Friederike Feldmann, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Ebola virus glycoprotein domains associated with protective efficacy
Bharti Bhatia, Wakako Furuyama, Thomas Hoenen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Protein Vaccine Induces a Durable, More Broadly Neutralizing Antibody Response in Macaques than Natural Infection with SARS-CoV-2 P.1
Albert To, Teri Ann S. Wong, Michael M. Lieberman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access
Page 1

Scroll to top